Thang V Pham Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

10/2018

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thang V Pham Research Topics

Disease

46	Neoplasms (Cancer) 04/2024 - 12/2007
14	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 05/2010
6	Adenoma (Adenomas) 01/2022 - 05/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 09/2009
5	Carcinogenesis 09/2022 - 01/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2018
3	Adenocarcinoma 04/2024 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2016
3	Dementia (Dementias) 01/2023 - 01/2016
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2016
3	Inflammation (Inflammations) 01/2022 - 07/2012
3	Breast Neoplasms (Breast Cancer) 09/2016 - 07/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 06/2016
2	Prostatic Neoplasms (Prostate Cancer) 07/2023 - 01/2017
2	Frontotemporal Dementia (Semantic Dementia) 01/2023 - 01/2016
2	Cognitive Dysfunction 01/2023 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2016
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 06/2014
2	Lung Neoplasms (Lung Cancer) 11/2019 - 01/2019
2	Carcinoma (Carcinomatosis) 05/2014 - 05/2010
1	Triple Negative Breast Neoplasms 02/2024
1	Atrial Fibrillation 01/2023
1	Squamous Cell Carcinoma of Head and Neck 02/2022
1	Thrombosis (Thrombus) 01/2022
1	Pulmonary Hypertension 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Left Ventricular Outflow Obstruction 01/2021
1	Cholangiocarcinoma 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019
1	Chronic Renal Insufficiency 10/2019
1	Ciliopathies 10/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2009
33	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2007
16	ProteomeIBA 04/2024 - 05/2010
11	Phosphotransferases (Kinase)IBA 04/2024 - 10/2018
6	Peptides (Polypeptides)IBA 02/2021 - 09/2009
5	Tyrosine Kinase InhibitorsIBA 11/2023 - 09/2015
5	Sunitinib (Sutent)FDA Link 11/2023 - 06/2016
4	EnzymesIBA 04/2024 - 10/2013
4	Protein Kinase InhibitorsIBA 01/2022 - 10/2018
4	PhosphopeptidesIBA 01/2022 - 09/2015
3	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2017
3	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 06/2016
3	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 05/2013
2	CytokinesIBA 01/2024 - 01/2021
2	PlatinumIBA 11/2023 - 01/2019
2	bis(p-chlorophenyl)acetic acid (DDA)IBA 07/2023 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2017
2	PhosphotyrosineIBA 01/2022 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 07/2021 - 01/2010
2	Protein Kinases (Protein Kinase)IBA 02/2021 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 02/2020 - 10/2018
2	Everolimus FDA Link 02/2020 - 10/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2020 - 10/2018
2	Dasatinib (BMS 354825)FDA Link 02/2020 - 10/2018
2	AntigensIBA 01/2020 - 09/2014
2	Small Interfering RNA (siRNA)IBA 10/2017 - 06/2015
2	Kainic Acid (Kainate)IBA 08/2016 - 07/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 09/2014 - 11/2009
2	ChromatinIBA 05/2014 - 05/2010
1	Histones (Histone)IBA 04/2024
1	protein kinase DIBA 02/2024
1	ChemokinesIBA 01/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	Drug CombinationsIBA 01/2023
1	Amino Acids FDA Link 01/2022
1	von Willebrand FactorIBA 01/2022
1	epidermal growth factor receptor VIIIIBA 10/2021
1	serum P-component (CIt)IBA 02/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	ParaffinIBA 01/2021
1	TubulinIBA 01/2021
1	CDX2 Transcription FactorIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	VemurafenibIBA 02/2020
1	amsonic acid (DAS)IBA 02/2020
1	EphA2 ReceptorIBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	BilirubinIBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	HaptoglobinsIBA 01/2020
1	iodoHis(3)- neurokinin A (INKA)IBA 12/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Gemcitabine FDA Link 01/2019

Therapy/Procedure

7	Therapeutics 04/2024 - 03/2014
5	Drug Therapy (Chemotherapy) 11/2019 - 09/2009
2	Adjuvant Chemotherapy 11/2023 - 01/2016
1	Endarterectomy (Thromboendarterectomy) 01/2022